Subscription Required
Canada’s life sciences sector is on a roll. Current levels of venture capital investment are unprecedented. Dollar flows set a record last year, with C$1.1 billion ($830 million) deployed to 74 biotech companies, according to Thomson Reuters data. That exceeds the prior record in 2000 by 32 percent. The robust deal-making has continued in 2017. VC […]↧